Related Experiment Video
Updated: May 15, 2025
06:51
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
14.8K
Immunotherapy in chronic lymphocytic leukemia: advances and challenges
Pan Gao1, Yang Zhang1, Jun Ma1
1Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324, Jingwu Road, Jinan, Shandong, 250021, China.
Experimental Hematology & Oncology
|April 11, 2025
Summary
This review examines current immunotherapies for chronic lymphocytic leukemia (CLL), a B-cell malignancy. It compares treatment combinations to improve patient outcomes and quality of life.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) involves abnormal B-lymphocyte proliferation, impacting older adults.
- CLL patients face increased risks of infections and secondary cancers due to immune dysregulation.
- Immunotherapy has significantly improved prognosis and treatment for CLL.
Purpose of the Study:
- To review and analyze current immunotherapeutic strategies for CLL.
- To evaluate the efficacy, benefits, and drawbacks of existing treatments.
- To guide the selection of personalized treatment regimens and compare therapeutic combinations.
Main Methods:
- Systematic literature review of immunotherapies for CLL.
- Analysis of clinical trial data and treatment outcomes.
- Comparative assessment of different immunotherapeutic approaches and combinations.
Main Results:
- Immunotherapy has transformed CLL treatment, offering improved survival rates.
- Various immunotherapeutic agents and combinations show distinct efficacy profiles.
- Understanding treatment limitations is crucial for optimizing patient care.
Conclusions:
- Current immunotherapies offer substantial benefits for CLL patients.
- Tailoring treatment strategies based on individual needs enhances prognosis.
- Further research into therapeutic combinations aims to maximize patient survival and quality of life.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
01:20Special Features of Adaptive Immunity
625
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
625
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K